RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2008; 133(8): 367-369
DOI: 10.1055/s-2008-1046721
DOI: 10.1055/s-2008-1046721
Kommentar | Commentary
Infektiologie, Gastroenterologie© Georg Thieme Verlag KG Stuttgart · New York
Probiotika - evidenzbasierte Medizin oder alternativmedizinischer Hokuspokus?
Probiotics - evidence-based medicine or simply hocus-pocus?Weitere Informationen
Publikationsverlauf
eingereicht: 16.10.2007
akzeptiert: 21.1.2008
Publikationsdatum:
13. Februar 2008 (online)

Schlüsselwörter
Probiotika - Indikationen - Wirkmechanismus - klinische Studien
Key words
probiotics - usage - mechanism of action - clinical studies
Literatur
- 1
Abrahamsson T R, Jakobsson T, Bottcher M F, Fredrikson M, Jenmalm M C, Bjorksten B, Oldaeus G.
Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled
trial.
J Allergy Clin Immunol.
2007;
119
1174-1180
Reference Ris Wihthout Link
- 2
Brouwer M L, Wolt-Plompen S A, Dubois A E, van der Heide S, Jansen D F, Hoijer M A, Kauffman H F, Duiverman E J.
No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled
trial.
Clin Exp Allergy.
2006;
36
899-906
Reference Ris Wihthout Link
- 3
Floch M H, Madsen K K, Jenkins D J, Guandalini S, Katz J A, Onderdonk A, Walker W A, Fedorak R N, Camilleri M.
Recommendations for probiotic use.
J Clin Gastroenterol.
2006;
40
275-278
Reference Ris Wihthout Link
- 4
Gruber C, Wendt M, Sulser C, Lau S, Kulig M, Wahn U, Werfel T, Niggemann B.
Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of
atopic dermatitis in infancy.
Allergy.
2007;
62
1270-1276
Reference Ris Wihthout Link
- 5
Helin T, Haahtela S, Haahtela T.
No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus
(ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study.
Allergy.
2002;
57
243-246
Reference Ris Wihthout Link
- 6
Huang J S, Bousvaros A, Lee J W, Diaz A, Davidson E J.
Efficacy of probiotic use in acute diarrhea in children: a meta-analysis.
Dig Dis Sci.
2002;
47
2625-2634
Reference Ris Wihthout Link
- 7
Huys G, Vancanneyt M, D’Haene K, Vankerckhoven V, Goossens H, Swings J.
Accuracy of species identity of commercial bacterial cultures intended for probiotic
or nutritional use.
Res Microbiol.
2006;
157
803-810
Reference Ris Wihthout Link
- 8
Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E.
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled
trial.
Lancet.
2001;
357
1076-1079
Reference Ris Wihthout Link
- 9
Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E.
Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled
trial.
Lancet.
2003;
361
1869-1871
Reference Ris Wihthout Link
- 10 Kopp M, Hennemuth I, Dietschek A, Goldstein M, Ihorst G, Heinzmann A, Urbanek R. A randomized, double-blind, placebo-controlled trial of probiotics for primary prevention:
No clinical or immunological effects of Lactobacillus GG supplementation. Pediatrics in press
Reference Ris Wihthout Link
- 11
Kruis W, Fric P, Pokrotnieks J, Lukas M, Fixa B, Kascak M, Kamm M A, Weismueller J, Beglinger C, Stolte M, Wolff C, Schulze J.
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle
1917 is as effective as with standard mesalazine.
Gut.
2004;
53
1617-1623
Reference Ris Wihthout Link
- 12
McFarland L V.
Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and
the treatment of Clostridium difficile disease.
Am J Gastroenterol.
2006;
101
812-822
Reference Ris Wihthout Link
- 13
McFarland L V.
Meta-analysis of probiotics for the prevention of traveler’s diarrhea.
Travel Med Infect Dis.
2007;
5
97-105
Reference Ris Wihthout Link
- 14
Salminen M K, Tynkkynen S, Rautelin H, Saxelin M, Vaara M, Ruutu P, Sarna S, Valtonen V, Jarvinen A.
Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus
rhamnosus GG in Finland.
Clin Infect Dis.
2002;
35
1155-1160
Reference Ris Wihthout Link
- 15
Taylor A L, Dunstan J A, Prescott S L.
Probiotic supplementation for the first 6 months of life fails to reduce the risk
of atopic dermatitis and increases the risk of allergen sensitization in high-risk
children: a randomized controlled trial.
J Allergy Clin Immunol.
2007;
119
184-191
Reference Ris Wihthout Link
- 16
Van Niel C W, Feudtner C, Garrison M M, Christakis D A.
Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis.
Pediatrics.
2002;
109
678-684
Reference Ris Wihthout Link
- 17
Wang M F, Lin H C, Wang Y Y, Hsu C H.
Treatment of perennial allergic rhinitis with lactic acid bacteria.
Pediatr Allergy Immunol.
2004;
15
152-158
Reference Ris Wihthout Link
- 18
Weizman Z, Asli G, Alsheikh A.
Effect of a probiotic infant formula on infections in child care centers: comparison
of two probiotic agents.
Pediatrics.
2005;
115
5-9
Reference Ris Wihthout Link
Prof. Dr. med. Johannes Huebner
Infektiologie, Innere Medizin II, Universitätsklinikum Freiburg
Hugstetter Str. 55
79106 Freiburg
Telefon: 0761/270-1828
Fax: 0761/270-1820
eMail: johannes.huebner@uniklinik-freiburg.de
